OncoQR ’s S-TIR vaccine technology helps induce killing of cancer cells

Austrian start-up OncoQR ML has confirmed that a single therapeutic vaccine based on its Specific Total Immune Remodeler (S-TIR) platform is capable of simultaneously inducing and activating the killing of tumour target expressing cells.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news